Mainz Biomed BV (MYNZ)
Official siteDIAGNOSTICS & RESEARCH
Last updated: Nov 13, 2026 at 4:00 PM ET
Mainz Biomed BV (MYNZ) Financials: Revenue, Profit and Cash Flow
Mainz Biomed BV reported revenue of $893.99K for the fiscal year ended Dec 31, 2024, down 0.2% from the year before. That year, net income was -$21.65M with a net margin of -2421.8%, operating cash flow was -$17.09M and free cash flow was -$17.34M. The quarter ended Jun 30, 2025 had revenue of $286.72K and net income of -$8.34M.
Revenue and Margins
Over the 5 years to Dec 2024, revenue grew from $281.39K, a compound annual rate of 26.0%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2024 | $893.99K | -0.2% | 64.3% | -2091.2% | -2421.8% |
| Dec 2023 | $895.48K | +69.0% | 56.9% | -2975.5% | -2936.5% |
| Dec 2022 | $529.88K | -8.2% | 34.4% | -4990.6% | -4992.2% |
| Dec 2021 | $577.35K | +17.0% | 30.8% | -1684.4% | -2024.8% |
| Dec 2020 | $493.56K | +75.4% | 24.9% | -155.2% | -118.9% |
| Dec 2019 | $281.39K | N/A | -21.8% | -327.6% | -340.1% |
Income Statement
In the fiscal year ended Dec 2024, the net loss narrowed from the year before.
Annual
| Line item | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|
| Revenue | $893.99K | $895.48K | $529.88K | $577.35K | $493.56K | $281.39K |
| Cost of revenue | $319.11K | $385.82K | $347.73K | $399.73K | $370.48K | $342.66K |
| Gross profit | $574.88K | $509.66K | $182.15K | $177.62K | $123.08K | -$61.27K |
| Research and development | $5.84M | $9.59M | $3.66M | $466.69K | $311.85K | $250.32K |
| Operating income | -$18.70M | -$26.64M | -$26.44M | -$9.72M | -$766.09K | -$921.91K |
| Net income | -$21.65M | -$26.30M | -$26.45M | -$11.69M | -$586.89K | -$957.05K |
| EBITDA | N/A | -$25.01M | -$25.72M | N/A | -$257.64K | -$702.08K |
Quarterly
| Line item | Jun 2025 | Dec 2024 | Sep 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $286.72K | $373.22K | $520.77K | $214.76K | $214.76K | $181.67K | $500.21K | $251.40K | $144.34K | $96.79K | $278.48K | $160.04K |
| Gross profit | -$310.34K | $255.84K | $319.04K | $40.25K | $134.73K | $87.19K | $277.88K | $33.41K | N/A | $18.61K | $148.74K | -$174.92K |
| Operating income | -$8.09M | -$8.89M | -$9.81M | -$12.23M | -$6.80M | -$5.64M | -$12.98M | -$12.28M | N/A | -$5.48M | -$13.90M | -$9.47M |
| Net income | -$8.34M | -$10.63M | -$11.02M | -$5.18M | -$5.18M | -$6.30M | -$13.27M | -$12.58M | N/A | -$5.60M | -$13.88M | -$11.43M |
Balance Sheet
As of Dec 2024, cash and equivalents exceeded short-term debt of $2.41M by $3.83M.
Annual
| Line item | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|
| Total assets | $13.24M | $15.41M | $20.24M | $10.04M | $673.27K | $715.96K |
| Current assets | $7.84M | $8.98M | $18.38M | $9.61M | $186.40K | $260.01K |
| Cash and equivalents | $6.24M | $7.07M | $17.14M | $8.73M | $122.57K | $203.59K |
| Total liabilities | $7.19M | $12.16M | $6.14M | $3.68M | $3.41M | $2.67M |
| Short-term debt | $2.41M | $5.22M | $1.33M | $248.51K | $266.63K | $207.26K |
| Long-term debt | N/A | $1.03M | $943.21K | $1.94M | $447.18K | $369.48K |
| Shareholder equity | $6.05M | $3.25M | $14.10M | $6.36M | -$2.74M | -$1.95M |
Quarterly
| Line item | Jun 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $9.80M | $13.24M | $8.45M | $8.45M | $15.41M | $15.41M | $17.91M | $19.31M | $20.24M | $20.24M | N/A | $27.62M |
| Total liabilities | $7.28M | $7.19M | $12.59M | $12.59M | $12.16M | $12.16M | $14.46M | $14.13M | $6.14M | $6.14M | N/A | $3.84M |
| Cash and equivalents | $1.91M | $6.24M | $977.76K | $977.76K | $7.07M | $7.07M | $9.32M | $10.91M | $17.14M | $17.14M | N/A | $26.01M |
| Shareholder equity | $2.52M | $6.05M | -$4.14M | -$4.14M | $3.25M | $3.25M | $3.45M | $5.18M | $14.10M | $14.10M | N/A | $23.77M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2024.
Annual
| Line item | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$17.09M | -$21.94M | -$14.77M | -$3.22M | -$468.74K | -$416.50K |
| Capital expenditures | $254.95K | $1.90M | $658.48K | $16.70K | $9.69K | $9.69K |
| Free cash flow | -$17.34M | -$23.84M | -$15.43M | -$3.24M | -$478.42K | -$426.18K |
| Investing cash flow | -$198.82K | -$1.90M | -$658.48K | $1.20M | -$9.69K | -$9.69K |
| Financing cash flow | $16.60M | $14.23M | $23.94M | $10.61M | $396.68K | $424.00K |
Quarterly
| Line item | Jun 2025 | Dec 2024 | Sep 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$6.52M | -$8.95M | -$8.14M | -$4.66M | -$4.66M | -$6.51M | -$5.12M | -$8.31M | -$805.08K |
| Capital expenditures | $1.12K | $134.29K | $120.66K | $261.81K | $261.81K | $112.48K | $123.63K | $406.04K | N/A |
| Free cash flow | -$6.52M | -$9.08M | -$8.27M | -$4.92M | -$4.92M | -$6.62M | -$5.24M | -$8.72M | N/A |
Frequently Asked Questions About MYNZ
What is Mainz Biomed BV's annual revenue?
Mainz Biomed BV reported revenue of $893.99K for the fiscal year ended Dec 31, 2024.
How fast is Mainz Biomed BV's revenue growing?
Revenue was down 0.2% for the fiscal year ended Dec 31, 2024 compared with the year before. The compound annual revenue growth rate over 3 years was 15.7%.
Is Mainz Biomed BV profitable?
No. Mainz Biomed BV reported net income of -$21.65M for the fiscal year ended Dec 31, 2024, with a net margin of -2421.8%.
How much free cash flow does MYNZ generate?
For the fiscal year ended Dec 31, 2024, operating cash flow of -$17.09M minus capital expenditures of $254.95K produced free cash flow of -$17.34M.
How much debt does Mainz Biomed BV have?
The balance sheet dated Dec 31, 2024 reported short-term debt of $2.41M and cash and equivalents of $6.24M.
MYNZ pages: Overview, Financials